Seyltx Gains Option to Boost Cough Pipeline with 8 NeurOp Drugs
05 Jun 2025 //
BUSINESSWIRE
Seyltx Reports Positive Pre-Clinical Data For GluN2B Inhibitor In Cough
16 Jul 2024 //
GLOBENEWSWIRE
Seyltx Announces Refractory Chronic Cough Prevalence Study Results
09 Jul 2024 //
GLOBENEWSWIRE